Matthew Klein - Chief Operating Officer, Ptc Therapeutics, Inc

As of January 11, 2022


Matthew Klein Net Worth

  • Net worth is estimated to be at least $1.53M
  • Owns at least 57,461 units of Ptc Therapeutics, Inc stock
  • Sold an estimated value of $1.1M in the last 2 years at Ptc Therapeutics, Inc

Matthew Klein Trading

  • Largest purchase of shares was 5,500 units , worth over $214.39K on January 12, 2021
  • Largest sale of shares was 5,500 units , worth over $383.41K on January 12, 2021
  • In total has made about 6 transactions over 2 years
  • Usually trades in January, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Matthew Klein Mailing Address

  • Mailing address is C/o Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 NJ

Ptc Therapeutics, Inc Insider Trading

  • The most recent transaction was 11,428 units sold on January 20, 2022 by Marie Christine Utter worth over $502.12K
  • In the last 9 years, insiders at Ptc Therapeutics, Inc sold an estimated value of $157.95M and bought an estimated value of $100.92M
  • The most active traders are Walter Stuart Peltz, Chief Executive Officer,  Gregory Neil Almstead, Chief Technical Ops Officer,  and Mark Rothera, Chief Commercial Officer
  • Insider trading is most common in January, with the busiest year in 2020

PTC THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1